The Marked Chart Wire · Business
Merck
Merck sells US contract manufacturing unit to Lonza
Merck has agreed to exit its US contract development and manufacturing organization business by selling the division to Lonza.
The stocks in this story
Prices from Before the open · based on Mon close · Opens 9:30 AM ET. Each tile opens the stock's chart and news.
New to this? Read: Reading a stock chart
More Business news
AI Security
CrowdStrike to acquire two AI security firms for $495 million
CrowdStrike is reportedly purchasing two artificial intelligence security startups in a deal valued at $495 million.
North West Shelf
Shell expects North West Shelf sale to close in 2027
Shell stated that the sale of its North West Shelf assets is anticipated to be finalized in 2027, provided all necessary regulatory approvals are secured.
Philips
Philips Q3 profit falls on legal costs, EBITDA rises
Koninklijke Philips reported a sharp drop in third-quarter profit due to a Respironics settlement provision, while adjusted EBITDA increased on higher sales. The company maintained its full-year 2026 outlook.
Palantir
Palantir third-quarter revenue rises 96 percent to $2.3 billion
Palantir posted $2.3 billion in sales for the third quarter, marking a 96 percent jump from the prior-year period.
BioMarin
BioMarin forecasts 2026 revenue of $3.8B to $3.9B
BioMarin projects full-year 2026 revenue between $3.8 billion and $3.9 billion. The company also noted $70 million in order deferrals.
Vertex
Vertex sets 2026 revenue guidance at $13.15 billion to $13.25 billion
Vertex Pharmaceuticals projects 2026 revenue between $13.15 billion and $13.25 billion. The guidance includes $40 million to $50 million from Crinetics.
Fast headlines, summarized. Not verified and not advice. Check the full story before you act.